Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis?

被引：1
|
作者：
Horn, Paul [1 ,2 ,3 ,4 ]
Newsome, Philip N. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, Birmingham, W Midlands, England
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England
[4] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 51卷 / 10期
关键词：
FATTY LIVER-DISEASE;
D O I：
10.1111/apt.15682
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：987 / 988
页数：2
相关论文
共 50 条
  • [31] ADVANCED FIBROSIS IS ASSOCIATED WITH INCIDENT CARDIOVASCULAR DISEASE IN PATIENTS WITH BIOPSY-PROVEN NAFLD
    Henson, Jacqueline
    Simon, Tracey G.
    Kaplan, Alyson
    Masia, Ricard
    Osganian, Stephanie
    Corey, Kathleen E.
    HEPATOLOGY, 2019, 70 : 713A - 714A
  • [32] Non-invasive measures of liver fibrosis in NAFLD is associated with cardiovascular risk
    Niederseer, David
    Bachmayer, Sebastian
    Stadlmayr, Andreas
    Huber-Schoenauer, Ursula
    Lederer, Dieter
    Schmied, Christian
    Hammerl, Sabrina
    Aigner, Elmar
    Ploederl, Martin
    Patsch, Wolfgang
    Datz, Christian
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E289 - E290
  • [33] Association of non-invasive measures of liver fibrosis in nafld with cardiovascular risk
    Tewari, Awanish
    Premkumar, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 379 - 379
  • [34] Association of Cardiovascular Disease With Transition From Low to High-Risk for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
    Quiroga, Myra
    Schreiner, Andrew
    Zhang, JingweN
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1028 - S1029
  • [35] Re-Thinking Elective Single Embryo Transfer: Increased Risk of Monochorionic Twinning - A Systematic Review
    Dziadosz, Margaret
    Evans, Mark I.
    FETAL DIAGNOSIS AND THERAPY, 2017, 42 (02) : 81 - 91
  • [36] NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
    Targher, Giovanni
    Corey, Kathleen E.
    Byrne, Christopher D.
    DIABETES & METABOLISM, 2021, 47 (02)
  • [37] Mediterranean Diet lowers cardiovascular Risk Factors in NAFLD-Patients
    Gappa, Birgit
    AKTUELLE ERNAHRUNGSMEDIZIN, 2020, 45 (04):
  • [38] Genetic risk factors for NAFLD and clinically significant fibrosis in persons living with HIV
    Gomez, Eduardo Vilar
    Gawrieh, Samer
    Liang, Tiebing
    Lake, Jordan
    Naggie, Susanna
    Woreta, Tinsay
    Price, Jennifer
    Sterling, Richard
    Heath, Sonya
    King, Holly
    Wilson, Laura
    Tonascia, James
    Bansal, Meena
    Corey, Kathleen
    Loomba, Rohit
    Sulkowski, Mark S.
    Chalasani, Naga
    JOURNAL OF HEPATOLOGY, 2023, 78 : S612 - S613
  • [39] Risk factors for significant fibrosis in non-obese Asian patients with NAFLD
    Jeong, Jae Yoon
    Cho, Ju-Yeon
    Kim, Jung Hee
    Cho, Yong Kyun
    Kim, Byung Ik
    Sohn, Won
    JOURNAL OF HEPATOLOGY, 2023, 78 : S637 - S637
  • [40] RACIAL DISPARITIES IN NAFLD-FIBROSIS RISK FACTORS IN THE UNITED STATES POPULATION
    Ma, Ning
    Ash, Nathaniel
    Bansal, Meena B.
    Branch, Andrea D.
    GASTROENTEROLOGY, 2023, 164 (06) : S1260 - S1260
12345